DocGo Inc. 8-K Summary: Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of DocGo Inc.'s 2026 Annual Meeting of Stockholders held on June 16, 2026. The record date for the meeting was April 20, 2026, with 98,778,413 shares of common stock entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Outcomes
Stockholders voted on six matters with the following results:
- Director Elections: Both Class II nominees, Vina Leite and James M. Travers, were elected to the Board of Directors.
- Executive Compensation: The non-binding advisory vote to approve named executive officer compensation was approved.
- Reverse Stock Split: Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-5 and 1-for-10, to be determined by the Board.
- Corporate Opportunity Waiver: The proposed amendment regarding the waiver of corporate opportunities was not approved.
- Officer Exculpation: The proposed amendment to limit the liability of certain officers was not approved.
- Auditor Ratification: Stockholders ratified the appointment of Urish Popeck & Co., LLC as the independent registered public accounting firm for the year ending December 31, 2026.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or specific risk disclosures beyond the standard reporting of the voting results. The failure to approve the Corporate Opportunity and Officer Exculpation amendments indicates shareholder resistance to specific governance changes.
Key Facts for Investor Verification
- Verify the specific reverse stock split ratio selected by the Board of Directors following shareholder approval.
- Monitor the Board's response to the rejection of the Corporate Opportunity and Officer Exculpation amendments.
- Confirm the effective date of the reverse stock split and its impact on share count and trading price.
- Review the upcoming 10-K or 10-Q filings for the financial metrics absent from this 8-K.